Immunic, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-46.1M | $-46.3M | $146.0K | $2.7M |
| FY2021 | $-83.2M | $-83.3M | $67.0K | $5.9M |
| FY2022 | $-65.1M | $-65.3M | $112.0K | $7.9M |
| FY2023 | $-70.8M | $-71.2M | $334.0K | $7.1M |
| FY2024 | $-84.8M | $-85.0M | $264.0K | $8.5M |